Four Strategies For Reducing Ridiculously Inflated Drug Prices

American consumers pay hundreds of billion of dollars in inflated pharmaceutical prices because drug companies are legal monopolies, a result of current patent laws. Dean Baker of the Center for Economic and Policy Research evaluates 4 separate strategies for slashing the cost of drugs and seeing drugs as a common good.

Avatar photo
Follow David Morris:
David Morris

David Morris is co-founder of the Institute for Local Self-Reliance and currently ILSR's distinguished fellow. His five non-fiction books range from an analysis of Chilean development to the future of electric power to the transformation of cities and neighborhoods.  For 14 years he was a regular columnist for the Saint Paul Pioneer Press. His essays on public policy have appeared in the New York TimesWall Street Journal, Washington PostSalonAlternetCommon Dreams, and the Huffington Post.